Haoxi Health Technology Limited
HAO
$1.23
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.98M | 11.98M | 12.51M | 12.51M | 11.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.98M | 11.98M | 12.51M | 12.51M | 11.75M |
| Cost of Revenue | 11.74M | 11.74M | 11.73M | 11.73M | 11.15M |
| Gross Profit | 240.20K | 240.20K | 774.50K | 774.50K | 600.70K |
| SG&A Expenses | 270.10K | 270.10K | 300.50K | 300.50K | 176.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.04M | 12.04M | 12.06M | 12.06M | 11.34M |
| Operating Income | -63.70K | -63.70K | 449.40K | 449.40K | 409.20K |
| Income Before Tax | 1.00K | 1.00K | 467.50K | 467.50K | 400.10K |
| Income Tax Expenses | 117.30K | 117.30K | 201.80K | 201.80K | 20.00K |
| Earnings from Continuing Operations | -116.30K | -116.30K | 265.70K | 265.70K | 380.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -116.30K | -116.30K | 265.70K | 265.70K | 380.10K |
| EBIT | -63.70K | -63.70K | 449.40K | 449.40K | 409.20K |
| EBITDA | -58.90K | -58.90K | 452.10K | 453.10K | 415.00K |
| EPS Basic | -0.06 | -0.06 | 0.21 | 0.21 | 0.32 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.23 | 0.23 | 0.21 |
| EPS Diluted | -0.06 | -0.06 | 0.21 | 0.21 | 0.32 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.23 | 0.23 | 0.21 |
| Average Basic Shares Outstanding | 1.81M | 1.81M | 1.27M | 1.27M | 1.18M |
| Average Diluted Shares Outstanding | 1.81M | 1.81M | 1.27M | 1.27M | 1.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |